Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 7.96 is 34% below its 5-year average of 12.13, near the low end of its 5-year range (7.02–20.91).
As of the fiscal period ended Tuesday, June 30, 2026. 12.79% below its 12-month average of 9.13.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.96.
QUICK RATIO (ACID-TEST)
7.96
QUICK RATIO (ACID-TEST) AVG TTM
9.13
QUICK RATIO (ACID-TEST) AVG 3Y
9.14
QUICK RATIO (ACID-TEST) AVG 5Y
12.13
QUICK RATIO (ACID-TEST) AVG 10Y
24.72
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-12.79%
CURRENT VS 3Y AVG
-12.95%
CURRENT VS 5Y AVG
-34.38%
CURRENT VS 10Y AVG
-67.80%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 623 covered companies
CURRENT VS SECTOR MEDIAN
+166.22%
vs the sector median at left
Krystal Biotech, Inc.
Market Cap
$9.53B
Quick Ratio (Acid-Test)
7.96
TTM Avg
9.13
3Y Avg
9.14
5Y Avg
12.13
Market Cap
$9.73B
Quick Ratio (Acid-Test)
0.73
TTM Avg
0.77
3Y Avg
0.86
5Y Avg
0.88
Market Cap
$9.12B
Quick Ratio (Acid-Test)
0.92
TTM Avg
0.82
3Y Avg
1.02
5Y Avg
1.25
Market Cap
$10.02B
Quick Ratio (Acid-Test)
2.33
TTM Avg
4.52
3Y Avg
4.42
5Y Avg
3.69
Market Cap
$10.04B
Quick Ratio (Acid-Test)
1.21
TTM Avg
1.49
3Y Avg
1.44
5Y Avg
1.33
Market Cap
$10.11B
Quick Ratio (Acid-Test)
1.68
TTM Avg
1.66
3Y Avg
1.58
5Y Avg
1.56
Market Cap
$8.77B
Quick Ratio (Acid-Test)
0.92
TTM Avg
0.82
3Y Avg
1.02
5Y Avg
1.25
Market Cap
$10.30B
Quick Ratio (Acid-Test)
5.70
TTM Avg
4.14
3Y Avg
3.40
5Y Avg
2.70
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | $9.53B | 7.96 | 9.13 | 9.14 | 12.13 |
| Insulet Corp. (PODD)vs › | $9.34B | 1.83 | 2.42 | 2.51 | 3.28 |
| Henry Schein, Inc. (HSIC)vs › | $9.73B | 0.73 | 0.77 | 0.86 | 0.88 |
| Bruker Corporation (BRKR)vs › | $9.12B | 0.92 | 0.82 | 1.02 | 1.25 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.02B | 2.33 | 4.52 | 4.42 | 3.69 |
| The Ensign Group, Inc. (ENSG)vs › | $10.04B | 1.21 | 1.49 | 1.44 | 1.33 |
| Molina Healthcare, Inc. (MOH)vs › | $10.11B | 1.68 | 1.66 | 1.58 | 1.56 |
| Bruker Corporation (BRKRP)vs › | $8.77B | 0.92 | 0.82 | 1.02 | 1.25 |
| ImmunityBio, Inc. (IBRX)vs › | $10.30B | 5.70 | 4.14 | 3.40 | 2.70 |
| Axsome Therapeutics, Inc. (AXSM)vs › | $8.79B | 1.34 | 1.76 | 2.38 | 3.52 |
Quick Ratio
7.96
Excludes inventory
Current Ratio
8.32
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 7.96 |
| 2026-03-31 | 9.06 |
| 2025-12-31 | 9.56 |
| 2025-09-30 | 9.73 |
| 2025-06-30 | 9.33 |
| 2025-03-31 | 9.27 |
| 2024-12-31 | 7.02 |
| 2024-09-30 | 7.76 |
| 2024-06-30 | 9.33 |
| 2024-03-31 | 12.42 |
| 2023-12-31 | 17.55 |
| 2023-09-30 | 20.91 |
| 2023-06-30 | 20.25 |
| 2023-03-31 | 10.13 |
| 2022-12-31 | 13.30 |
| 2022-09-30 | 14.18 |
| 2022-06-30 | 12.45 |
| 2022-03-31 | 7.25 |
| 2021-12-31 | 17.18 |
| 2021-09-30 | 9.67 |
| 2021-06-30 | 20.42 |
| 2021-03-31 | 44.38 |
| 2020-12-31 | 17.80 |
| 2020-09-30 | 39.96 |
| 2020-06-30 | 51.20 |
| 2020-03-31 | 46.38 |
| 2019-12-31 | 58.88 |
| 2019-09-30 | 54.87 |
| 2019-06-30 | 49.80 |
| 2019-03-31 | 33.28 |
| 2018-12-31 | 43.39 |
| 2018-09-30 | 27.57 |
| 2018-06-30 | 60.22 |
| 2018-03-31 | 105.46 |
| 2017-12-31 | 77.99 |
| 2017-09-30 | 21.26 |
| 2017-06-30 | 6.73 |
| 2017-03-31 | 25.08 |
| 2016-12-31 | 50.44 |
| 2016-09-30 | 0.00 |
